Literature DB >> 18599338

A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes.

Monica Lucattelli1, Benedetta Lunghi, Silvia Fineschi, Vincenzo Mirone, Roberta d'Emmanuele di Villa Bianca, Nicola Longo, Ciro Imbimbo, Raffaele De Palma, Raffaella Sorrentino, Giuseppe Lungarella, Giuseppe Cirino.   

Abstract

Peyronie's disease (PD) is characterized by an inflammatory response beneath the tunica albuginea with fibroblast proliferation forming a thickened fibrous plaque that may cause pain, penile curvature and erectile dysfunction. The progression of the PD plaque may eventually lead to calcification or ossification. Current therapeutic success is often unsatisfactory because of limited insight into disease mechanisms. Research has been hampered by the lack of a universally accepted animal model. We describe an animal model of spontaneous PD in tight skin (Tsk) mice, a C57Bl/6J subline that reproduces with age important features of the human disease (fibrous plaque formation, penile bending and areas of chondroid metaplasia with heterotopic ossification). Histological analysis demonstrated an evident structural disorganization of the tunica albuginea with excessive accumulation of type I collagen. At 12 months of age, fibrous plaques with areas of chondroid metaplasia and heterotopic ossification characterized Tsk penises. The up-regulation of hypoxia-inducible factor-1 (HIF-1) leads to an increased downstream expression of HIF-1 target genes, such as TGFbeta and iNOS. These factors, together with some PDGF family members, can cause collagen deposition in Tsk penises. They can also influence chondrocyte differentiation and heterotopic bone formation. In conclusion, hypoxia, HIF-1 and HIF-1 target genes appear to play an important role in the pathogenesis of PD in Tsk mice. This mouse model that is the first example of naturally occurring model of PD in laboratory animals may aid in the identification of signalling pathways crucial for PD and should facilitate the designing and testing of new therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599338     DOI: 10.1016/j.biocel.2008.05.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  9 in total

1.  Is Peyronie's an IgG4-related disease?

Authors:  Mehmet Solakhan; Bünyamin Kısacık
Journal:  Eur J Rheumatol       Date:  2020-07-27

Review 2.  Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

3.  Solving a bottleneck in animal models of Peyronie's disease.

Authors:  Selim Cellek; William Stebbeds; David J Ralph
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

4.  Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.

Authors:  Ludovic Ferretti; Thomas M Fandel; Xuefeng Qiu; Haiyang Zhang; Hazem Orabi; Alex K Wu; Lia Banie; Guifang Wang; Guiting Lin; Ching-Shwun Lin; Tom F Lue
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

5.  3D reconstruction and histopathological analyses on murine corporal body.

Authors:  Daiki Hashimoto; Mizuki Kajimoto; Yuko Ueda; Taiju Hyuga; Kota Fujimoto; Saaya Inoue; Kentaro Suzuki; Tomoya Kataoka; Kazunori Kimura; Gen Yamada
Journal:  Reprod Med Biol       Date:  2021-02-09

6.  Bioinformatics-Based Identification of Potential Hypoxia-Related Genes Associated With Peyronie's Disease.

Authors:  Yuanshan Cui; Yajuan Wang; Changping Men; Jitao Wu; Lingling Liu
Journal:  Am J Mens Health       Date:  2022 Jul-Aug

Review 7.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 8.  The pathophysiology of Peyronie's disease.

Authors:  Ahmed I El-Sakka; Emre Salabas; Murat Dinçer; Ates Kadioglu
Journal:  Arab J Urol       Date:  2013-08-07

9.  The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease.

Authors:  Carla Loreto; Giampiero La Rocca; Rita Anzalone; Rosario Caltabiano; Giuseppe Vespasiani; Sergio Castorina; David J Ralph; Selim Cellek; Giuseppe Musumeci; Salvatore Giunta; Rados Djinovic; Dragoslav Basic; Salvatore Sansalone
Journal:  Biomed Res Int       Date:  2014-08-13       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.